Rebecca Previs retweetledi
Comprehensive Genomic Profiling: A Required Tool for Precision Oncology @ASCO @ASCOPost @OncoAlert #ASCO23 @weoncologists
ascopubs.org/doi/10.1200/AD…
English
Rebecca Previs
723 posts
Rebecca Previs
@BeccaPrevisMD
Dir of Med Affairs at Labcorp Oncology; Gyn Onc; Duke adjunct. Pet mom to 🐶🐶🐱🦔🐭🐓🐝; passionate about pollination, gardening & piano. Opinions are mine.
Durham, NC Katılım Mart 2017
499 Takip Edilen1K Takipçiler
@VivekSubbiah presenting at #asco2023 that prior single gene testing limits the performance of CGP and negatively impacts CGP turn around time and the identification of therapeutically relevant genomic variants in #NSCLC. Performing tissue based CGP is standard of care. @Labcorp
English
Rebecca Previs retweetledi
One more week until our live Ask the Expert Q&A with @Labcorp's @BeccaPrevisMD! Join us to learn how #personalized #medicine is transforming #breastcancer treatment and explore emerging targeted therapies for HER2-low breast cancer subtypes: us02web.zoom.us/webinar/regist…
English
Rebecca Previs retweetledi
Want to learn more about HER2-low breast cancer? Please tune into this webinar by my amazing colleague and oncologist, Dr. @BeccaPrevisMD as she leads important discussions around HER2-low breast cancer! 🙌🏻
Outcomes4Me@outcomes4me
Join us for our upcoming Ask the Expert Q&A with @BeccaPrevisMD from @Labcorp where she'll discuss how personalized medicine is transforming breast cancer treatment and emerging targeted therapies for HER2-low breast cancer subtypes. us02web.zoom.us/webinar/regist…
San Antonio, TX 🇺🇸 English
@CancerDocKo @Labcorp @OmniSeq @LabcorpDrugDev @ESeversonMDPhD Congrats @CancerDocKo and team!!👩⚕️🩺🧬
English
2/2 abstracts accepted for posters at #ASCO23. Couldn’t be happier! Thank you to my amazing team at @Labcorp oncology @OmniSeq @LabcorpDrugDev @ESeversonMDPhD @BeccaPrevisMD for all of your support! 💃🏻🙌🏻
English
Rebecca Previs retweetledi
👏🙌NRG GY018!! We did it - improved progression free survival in MMRd AND MMRp #EndometrialCancer. Standard of care == CHANGED! #SGOMtg #gyncsm #ImmunoOnc Congrats to @NRGonc
English
Check out @ElizabethABloom’s work today at #SGOMtg. She reports a molecular analysis of a retrospective cohort of patients with endometrial intraepithelial hyperplasia. 5% were dMMR; 4% were p53abn. @dukeobgyn #Previslab @KC_Strickland @pammiepeters @janicewon_ 🧪🔬👩🔬🧬
English
Mentoring is one of life’s greatest privileges—and it’s not about creating clones but giving the space for each to create themselves and their own authentic paths. Couldn’t be prouder of @pammiepeters and @ElizabethABloom. ⭐️ 👩🔬🔬🧬🧪#WomenInSTEM #sgomtg #PatientsPurposeProgress
English
Checkpoint inhibition has had limited efficacy in high grade epithelial cancer. So proud of @pammiepeters and her work evaluating MEM-288, a novel oncolytic adenovirus, demonstrating efficacy and generating a systemic immune response. #SGOMtg @dukeobgyn #PatientsPurposeProgress
English
Rebecca Previs retweetledi
Our fellow Pamela Peters discussing her work on MEM-288 under mentor @BeccaPrevisMD proud of her work to improve the understanding of ovarian cancer immune response @dukeobgyn
English
The data are in! Cryocompression therapy works during chemo and prevents subjective neuropathy in patients with gyn cancers. Congrats @MKMontesDeOca @LHavrilesky and @dukeobgyn team. #SGOMtg #PatientsPurposeProgress
English
Thank you @Stigetta and @womenofteal for being a voice and a light. We are grateful for your advocacy, leadership, and reminding us of our purpose. #SGOMtg #PatientsPurposeProgress
English
Rebecca Previs retweetledi
Standing room only for Dr. Britta Weigelt’s discussion of circulating tumor DNA! #SGO2023 @MSKPathology @SGO_org
English
English
Congrats to @DukeMedSchool’s @LindaM_Zambrano and her important work highlighting funding to lethality scores in patients with cancer. Despite its increase in mortality, #uterinecancer remains underfunded. This work informs policy change, advocacy and equitable funding. #sgomtg
English
If you will be at the #ASH22 meeting next week, check out my @Labcorp teammate, @ESeversonMDPhD's presentation. 💜 the #ASHaiku! @ASH_hematology
Eric Severson@ESeversonMDPhD
Getting ready for the #ASH22 meeting with my #ASHaiku: ASH workshop with me December 10th, New Orleans Hemepath with @Labcorp @ASH_hematology
English
We analyzed ClinicalTrials,gov and found <10% of trials enrolling patients with gyn cancers report racial/ethnicity. We need diversity+transparency in enrollment. bit.ly/3Fdz49y @tomi_akinyemiju @MKMontesDeOca @BenPeipert @dukeobgyn @DukeCancer @Labcorp @ESeversonMDPhD
English
Rebecca Previs retweetledi
Healthcare Access Dimensions and Guideline-Concordant #OvarianCancer Treatment: SEER-Medicare Analysis of the ORCHiD Study: jnccn.org/view/journals/…
@MKMontesdeOca @BeccaPrevisMD @anjaligupta1680 @MariaPisu1 @MLiangMD @Kevin_C_Ward @AndrewBerchuck @tomi_akinyemiju
#hsronc #GynCSM
English